PCI or CABG for Left Main Coronary Artery Disease
To the Editor: In the EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial (Nov. 7 issue), 1 Stone et al. report no significant difference in the 5-year composite outcome of death, stroke, or myocardial infarction among patients wi...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2020-07, Vol.383 (3), p.290-294 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 294 |
---|---|
container_issue | 3 |
container_start_page | 290 |
container_title | The New England journal of medicine |
container_volume | 383 |
creator | Taggart, David P Gaudino, Mario Lozano, Iñigo Rondan, Juan Vegas, Jose M Lopez-Ayala, Pedro Koechlin, Luca Mueller, Christian Kapoor, Saloni Mulukutla, Suresh Bakaeen, Faisal G Svennson, Lars G Stone, Gregg W Serruys, Patrick W Sabik, Joseph F |
description | To the Editor:
In the EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial (Nov. 7 issue),
1
Stone et al. report no significant difference in the 5-year composite outcome of death, stroke, or myocardial infarction among patients with stable left main coronary artery disease who underwent either percutaneous coronary intervention (PCI) with drug-eluting stents or coronary-artery bypass grafting (CABG). We have three fundamental concerns regarding these findings. First, the incidence of death from any cause was 13.0% in the PCI group and 9.0% in the CABG group (odds ratio, 1.38; 95% confidence interval . . . |
doi_str_mv | 10.1056/NEJMc2000645 |
format | Article |
fullrecord | <record><control><sourceid>proquest_mms_n</sourceid><recordid>TN_cdi_proquest_journals_2424136818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2424136818</sourcerecordid><originalsourceid>FETCH-LOGICAL-m142t-94bae28809a57dfa358e857d297db50bd109211abc7db273be5a75d1a3d4c2d23</originalsourceid><addsrcrecordid>eNpNkD1PwzAYhC0EEqGw8QMswRp4X38k9lhCKUUpMMBsObEjNSIJ2OnAv8eoDEx3Jz26k46QS4QbBFncPq-eti0DgELII5Kh5DwXAopjkgEwlYtS81NyFmOfGEChM4Kv1YZOgVbLuzXtkql9N9Ot3Y20msI02vBNl2H2Se530dvoz8lJZz-iv_jTBXl_WL1Vj3n9st5UyzofULA516KxnikF2srSdZZL5VVyTJeukdA4BM0QbdOmzEreeGlL6dByJ1rmGF-Qq0PvZ5i-9j7Opp_2YUyThgkmkBcKVaKuD9QwRDP6fjAI5vcM8_8M_gNLwk4W</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424136818</pqid></control><display><type>article</type><title>PCI or CABG for Left Main Coronary Artery Disease</title><source>EZB-FREE-00999 freely available EZB journals</source><source>New England Journal of Medicine</source><creator>Taggart, David P ; Gaudino, Mario ; Lozano, Iñigo ; Rondan, Juan ; Vegas, Jose M ; Lopez-Ayala, Pedro ; Koechlin, Luca ; Mueller, Christian ; Kapoor, Saloni ; Mulukutla, Suresh ; Bakaeen, Faisal G ; Svennson, Lars G ; Stone, Gregg W ; Serruys, Patrick W ; Sabik, Joseph F</creator><creatorcontrib>Taggart, David P ; Gaudino, Mario ; Lozano, Iñigo ; Rondan, Juan ; Vegas, Jose M ; Lopez-Ayala, Pedro ; Koechlin, Luca ; Mueller, Christian ; Kapoor, Saloni ; Mulukutla, Suresh ; Bakaeen, Faisal G ; Svennson, Lars G ; Stone, Gregg W ; Serruys, Patrick W ; Sabik, Joseph F</creatorcontrib><description>To the Editor:
In the EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial (Nov. 7 issue),
1
Stone et al. report no significant difference in the 5-year composite outcome of death, stroke, or myocardial infarction among patients with stable left main coronary artery disease who underwent either percutaneous coronary intervention (PCI) with drug-eluting stents or coronary-artery bypass grafting (CABG). We have three fundamental concerns regarding these findings. First, the incidence of death from any cause was 13.0% in the PCI group and 9.0% in the CABG group (odds ratio, 1.38; 95% confidence interval . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMc2000645</identifier><language>eng</language><publisher>Boston: Massachusetts Medical Society</publisher><subject>Cardiovascular disease ; Cerebral infarction ; Coronary artery ; Coronary vessels ; Drug delivery ; Heart attacks ; Heart diseases ; Heart surgery ; Implants ; Myocardial infarction ; Stents</subject><ispartof>The New England journal of medicine, 2020-07, Vol.383 (3), p.290-294</ispartof><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2000645$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMc2000645$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2747,26080,27901,27902,52357,54039</link.rule.ids></links><search><creatorcontrib>Taggart, David P</creatorcontrib><creatorcontrib>Gaudino, Mario</creatorcontrib><creatorcontrib>Lozano, Iñigo</creatorcontrib><creatorcontrib>Rondan, Juan</creatorcontrib><creatorcontrib>Vegas, Jose M</creatorcontrib><creatorcontrib>Lopez-Ayala, Pedro</creatorcontrib><creatorcontrib>Koechlin, Luca</creatorcontrib><creatorcontrib>Mueller, Christian</creatorcontrib><creatorcontrib>Kapoor, Saloni</creatorcontrib><creatorcontrib>Mulukutla, Suresh</creatorcontrib><creatorcontrib>Bakaeen, Faisal G</creatorcontrib><creatorcontrib>Svennson, Lars G</creatorcontrib><creatorcontrib>Stone, Gregg W</creatorcontrib><creatorcontrib>Serruys, Patrick W</creatorcontrib><creatorcontrib>Sabik, Joseph F</creatorcontrib><title>PCI or CABG for Left Main Coronary Artery Disease</title><title>The New England journal of medicine</title><description>To the Editor:
In the EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial (Nov. 7 issue),
1
Stone et al. report no significant difference in the 5-year composite outcome of death, stroke, or myocardial infarction among patients with stable left main coronary artery disease who underwent either percutaneous coronary intervention (PCI) with drug-eluting stents or coronary-artery bypass grafting (CABG). We have three fundamental concerns regarding these findings. First, the incidence of death from any cause was 13.0% in the PCI group and 9.0% in the CABG group (odds ratio, 1.38; 95% confidence interval . . .</description><subject>Cardiovascular disease</subject><subject>Cerebral infarction</subject><subject>Coronary artery</subject><subject>Coronary vessels</subject><subject>Drug delivery</subject><subject>Heart attacks</subject><subject>Heart diseases</subject><subject>Heart surgery</subject><subject>Implants</subject><subject>Myocardial infarction</subject><subject>Stents</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpNkD1PwzAYhC0EEqGw8QMswRp4X38k9lhCKUUpMMBsObEjNSIJ2OnAv8eoDEx3Jz26k46QS4QbBFncPq-eti0DgELII5Kh5DwXAopjkgEwlYtS81NyFmOfGEChM4Kv1YZOgVbLuzXtkql9N9Ot3Y20msI02vBNl2H2Se530dvoz8lJZz-iv_jTBXl_WL1Vj3n9st5UyzofULA516KxnikF2srSdZZL5VVyTJeukdA4BM0QbdOmzEreeGlL6dByJ1rmGF-Qq0PvZ5i-9j7Opp_2YUyThgkmkBcKVaKuD9QwRDP6fjAI5vcM8_8M_gNLwk4W</recordid><startdate>20200716</startdate><enddate>20200716</enddate><creator>Taggart, David P</creator><creator>Gaudino, Mario</creator><creator>Lozano, Iñigo</creator><creator>Rondan, Juan</creator><creator>Vegas, Jose M</creator><creator>Lopez-Ayala, Pedro</creator><creator>Koechlin, Luca</creator><creator>Mueller, Christian</creator><creator>Kapoor, Saloni</creator><creator>Mulukutla, Suresh</creator><creator>Bakaeen, Faisal G</creator><creator>Svennson, Lars G</creator><creator>Stone, Gregg W</creator><creator>Serruys, Patrick W</creator><creator>Sabik, Joseph F</creator><general>Massachusetts Medical Society</general><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20200716</creationdate><title>PCI or CABG for Left Main Coronary Artery Disease</title><author>Taggart, David P ; Gaudino, Mario ; Lozano, Iñigo ; Rondan, Juan ; Vegas, Jose M ; Lopez-Ayala, Pedro ; Koechlin, Luca ; Mueller, Christian ; Kapoor, Saloni ; Mulukutla, Suresh ; Bakaeen, Faisal G ; Svennson, Lars G ; Stone, Gregg W ; Serruys, Patrick W ; Sabik, Joseph F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-m142t-94bae28809a57dfa358e857d297db50bd109211abc7db273be5a75d1a3d4c2d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cardiovascular disease</topic><topic>Cerebral infarction</topic><topic>Coronary artery</topic><topic>Coronary vessels</topic><topic>Drug delivery</topic><topic>Heart attacks</topic><topic>Heart diseases</topic><topic>Heart surgery</topic><topic>Implants</topic><topic>Myocardial infarction</topic><topic>Stents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taggart, David P</creatorcontrib><creatorcontrib>Gaudino, Mario</creatorcontrib><creatorcontrib>Lozano, Iñigo</creatorcontrib><creatorcontrib>Rondan, Juan</creatorcontrib><creatorcontrib>Vegas, Jose M</creatorcontrib><creatorcontrib>Lopez-Ayala, Pedro</creatorcontrib><creatorcontrib>Koechlin, Luca</creatorcontrib><creatorcontrib>Mueller, Christian</creatorcontrib><creatorcontrib>Kapoor, Saloni</creatorcontrib><creatorcontrib>Mulukutla, Suresh</creatorcontrib><creatorcontrib>Bakaeen, Faisal G</creatorcontrib><creatorcontrib>Svennson, Lars G</creatorcontrib><creatorcontrib>Stone, Gregg W</creatorcontrib><creatorcontrib>Serruys, Patrick W</creatorcontrib><creatorcontrib>Sabik, Joseph F</creatorcontrib><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taggart, David P</au><au>Gaudino, Mario</au><au>Lozano, Iñigo</au><au>Rondan, Juan</au><au>Vegas, Jose M</au><au>Lopez-Ayala, Pedro</au><au>Koechlin, Luca</au><au>Mueller, Christian</au><au>Kapoor, Saloni</au><au>Mulukutla, Suresh</au><au>Bakaeen, Faisal G</au><au>Svennson, Lars G</au><au>Stone, Gregg W</au><au>Serruys, Patrick W</au><au>Sabik, Joseph F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PCI or CABG for Left Main Coronary Artery Disease</atitle><jtitle>The New England journal of medicine</jtitle><date>2020-07-16</date><risdate>2020</risdate><volume>383</volume><issue>3</issue><spage>290</spage><epage>294</epage><pages>290-294</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor:
In the EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial (Nov. 7 issue),
1
Stone et al. report no significant difference in the 5-year composite outcome of death, stroke, or myocardial infarction among patients with stable left main coronary artery disease who underwent either percutaneous coronary intervention (PCI) with drug-eluting stents or coronary-artery bypass grafting (CABG). We have three fundamental concerns regarding these findings. First, the incidence of death from any cause was 13.0% in the PCI group and 9.0% in the CABG group (odds ratio, 1.38; 95% confidence interval . . .</abstract><cop>Boston</cop><pub>Massachusetts Medical Society</pub><doi>10.1056/NEJMc2000645</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 2020-07, Vol.383 (3), p.290-294 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_journals_2424136818 |
source | EZB-FREE-00999 freely available EZB journals; New England Journal of Medicine |
subjects | Cardiovascular disease Cerebral infarction Coronary artery Coronary vessels Drug delivery Heart attacks Heart diseases Heart surgery Implants Myocardial infarction Stents |
title | PCI or CABG for Left Main Coronary Artery Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T20%3A06%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_mms_n&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PCI%20or%20CABG%20for%20Left%20Main%20Coronary%20Artery%20Disease&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Taggart,%20David%20P&rft.date=2020-07-16&rft.volume=383&rft.issue=3&rft.spage=290&rft.epage=294&rft.pages=290-294&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMc2000645&rft_dat=%3Cproquest_mms_n%3E2424136818%3C/proquest_mms_n%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2424136818&rft_id=info:pmid/&rfr_iscdi=true |